Compile Data Set for Download or QSAR
maximum 50k data
Found 36 Enz. Inhib. hit(s) with all data for entry = 6118
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109719(US8618303, 9)
Affinity DataKi:  2.10nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109728(US8618303, 18)
Affinity DataKi:  2.80nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109740(US8618303, 30 | US8618303, 34)
Affinity DataKi:  2.90nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109720(US8618303, 10)
Affinity DataKi:  3.80nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109721(US8618303, 11)
Affinity DataKi:  4.5nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109717(US8618303, 7)
Affinity DataKi:  5nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109740(US8618303, 30 | US8618303, 34)
Affinity DataKi:  5.30nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109722(US8618303, 12)
Affinity DataKi:  7.60nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109741(US8618303, 31)
Affinity DataKi:  8.10nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109742(US8618303, 32)
Affinity DataKi:  9.90nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109723(US8618303, 13)
Affinity DataKi:  10nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109732(US8618303, 22)
Affinity DataKi:  10.5nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109711(US8618303, 1)
Affinity DataKi:  10.5nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109725(US8618303, 15)
Affinity DataKi:  11.5nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109714(US8618303, 4)
Affinity DataKi:  11.6nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109729(US8618303, 19)
Affinity DataKi:  12.9nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109718(US8618303, 8)
Affinity DataKi:  13nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109743(US8618303, 33)
Affinity DataKi:  20nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109712(US8618303, 2)
Affinity DataKi:  20.1nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109745(US8618303, 35)
Affinity DataKi:  21.3nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109739(US8618303, 29)
Affinity DataKi:  24.5nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109731(US8618303, 21)
Affinity DataKi:  31.9nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109727(US8618303, 17)
Affinity DataKi:  35.4nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109734(US8618303, 24)
Affinity DataKi:  39.2nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109733(US8618303, 23)
Affinity DataKi:  43.5nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109737(US8618303, 27)
Affinity DataKi:  51nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109716(US8618303, 6)
Affinity DataKi:  64.9nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109713(US8618303, 3)
Affinity DataKi:  67.8nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109724(US8618303, 14)
Affinity DataKi:  77.4nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109715(US8618303, 5)
Affinity DataKi:  86.4nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109735(US8618303, 25)
Affinity DataKi:  91.5nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109730(US8618303, 20)
Affinity DataKi:  276nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109726(US8618303, 16)
Affinity DataKi:  300nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109738(US8618303, 28)
Affinity DataKi:  348nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109736(US8618303, 26)
Affinity DataKi:  629nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM109746(US8618303, 36)
Affinity DataKi:  997nMAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
In DepthDetails US Patent